ELAB vs REGN: Which Stock is Better?
Side-by-side comparison of Pmgc Holdings Inc and Regeneron Pharmaceuticals Inc in 2026
ELAB
Pmgc Holdings Inc
$1.78
REGN
Regeneron Pharmaceuticals Inc
$634.62
Key Metrics Comparison
| Metric | ELAB | REGN | Winner |
|---|---|---|---|
| Market Cap | $8.09M | $66.98B | REGN |
| P/E Ratio | N/A | 15.60 | REGN |
| EPS (TTM) | $N/A | $40.95 | REGN |
| Revenue Growth | -0.5% | 0.2% | REGN |
| Gross Margin | -63.1% | 43.9% | REGN |
Analyze ELAB
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ELAB or REGN a better investment?
Comparing ELAB and REGN: Pmgc Holdings Inc has a market cap of $8.09M while Regeneron Pharmaceuticals Inc has $66.98B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ELAB and REGN?
ELAB (Pmgc Holdings Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ELAB or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ELAB or REGN?
REGN has higher revenue growth at 0.2% vs -0.5% for ELAB.
Which company is more profitable: ELAB or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 43.9% compared to -63.1% for ELAB.
Which is the larger company: ELAB or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $66.98B compared to $8.09M for ELAB.
Should I buy ELAB or REGN in 2026?
Both ELAB and REGN have investment merit. ELAB trades at $1.78 while REGN trades at $634.62. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ELAB and REGN stock?
Key differences: Market Cap ($8.09M vs $66.98B), P/E Ratio (N/A vs 15.6x), Revenue Growth (-0.5% vs 0.2%), Gross Margin (-63.1% vs 43.9%).